Micro-X Ltd
ASX:MX1

Watchlist Manager
Micro-X Ltd Logo
Micro-X Ltd
ASX:MX1
Watchlist
Price: 0.084 AUD -7.69% Market Closed
Market Cap: 56.1m AUD

Micro-X Ltd
Investor Relations

Micro-X Ltd. manufactures, designs, and develops ultra-lightweight carbon nanotube based X-ray products for the global healthcare and explosive device markets. The company is headquartered in Adelaide, South Australia. The company went IPO on 2015-12-22. The firm provides medical and security imaging products using cold cathode X-ray sources. The Company’s X-ray products include mobile digital X-ray machines, intermittent explosive disorder (IED) X-ray camera, miniature baggage scanner and computed tomography (CT) brain scanner. The Electronic X-Ray Tube is the foundation of its product development and innovation. The Company’s lead patented carbon nanotube technology ensures its products are lighter, smaller and more portable than traditional X-ray devices. The technology also develops X-ray imaging across the medical, defense, security screening and veterinary industries.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Nov 4, 2025
AI Summary
Q1 2026

Record Rover Plus Sale: Micro-X secured its largest ever Rover Plus order for $3.3 million, supplying the Malaysian Ministry of Health after winning a competitive government tender.

Head CT Progress: The Head CT for stroke diagnosis project reached final prototype stage; hospital trials are expected to start soon, pending administrative approvals.

Major Grants Secured: Micro-X received a $4.4 million grant from the Australian government to develop and trial the world’s first in-ambulance head CT scanner.

Security Contract Extension: The U.S. Department of Homeland Security extended its contract with Micro-X by $2.5 million, raising the total contract value to $31.7 million.

Strong Cash Inflows: The company saw cash inflows from product sales and project work, boosting its cash balance to $2 million at quarter end, with additional inflows received in October.

Robust Pipeline: Management reported strong momentum in both medical imaging and security segments, with growing interest from global partners and major healthcare networks.

Key Financials
Rover Plus Order
$3.3 million
Head CT Grant
$4.4 million
DHS Contract Value
$31.7 million
DHS Contract Extension
$2.5 million
Cash Inflows from Product Sales
$400,000
Cash Inflows from Medical Imaging Project Work
$1.4 million
Cash Inflows from Security Imaging Project Work
$3.6 million
Net Cash Outflows
$1.7 million
R&D Rebate Received
$5.1 million
Quarter-End Cash Balance
$2 million
Additional Cash Inflows (October)
$2.9 million
Other Earnings Calls

Management

Mr. Kingsley Hall BEC
Chief Executive Officer
No Bio Available
Mr. Anthony Skeats MEng (Hons)
Chief Operating Officer
No Bio Available
Dr. Brian Gonzales Ph.D.
CEO of US & Chief Scientific Officer
No Bio Available
Mr. Scott Bryant
Chief Sales Officer
No Bio Available

Contacts

Address
SOUTH AUSTRALIA
Adelaide
A14 6 MAB Eastern Promenade, 1284 South Road, Tonsley
Contacts
+61870993966.0
micro-x.com